Certified Advisory Corp Zynerba Pharmaceuticals, Inc. Transaction History

Certified Advisory Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 12, 2019	SELL	$7.56 - $15.44 $10,909 - $22,279	-1,443 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$5.4 - $15.5 $7,792 - $22,366	1,443 New	1,443 $20,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Certified Advisory Corp with notifications on news.